Earnings Feed
Start Free
STEPAN CO·4/A

Mar 5, 6:11 PM ET

Moriarty Sean Thomas 4/A

4/A · STEPAN CO · Filed Mar 5, 2026

Insider Transaction Report

Form 4/AAmended
Period: 2026-02-27
STEPAN COSCL
Moriarty Sean Thomas
VP & GM Surfactants
Transactions
  • Award

    Common Stock

    2026-02-27$52.51/sh+56.765$2,981→ 14,205.234 total
  • Award

    Stock Appreciation Right

    [F1][F2]
    2026-03-02+6,440→ 6,440 total
    Exercise: $17.47From: 2027-03-02Exp: 2036-03-03→ Common Stock (6,440 underlying)
  • Award

    Performance Shares

    [F3][F4]
    2026-03-02+2,247→ 2,247 total
    → Common Stock (2,247 underlying)
  • Award

    Restricted Stock Units

    [F5][F1]
    2026-03-02+4,495→ 4,495 total
    From: 2027-03-02Exp: 2029-03-02→ Restricted Stock Units (4,495 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    4,478.351
Footnotes (5)
  • [F1]Vest ratably over three years beginning on the date shown.
  • [F2]The Reporting Person's Form 4 filed on March 4, 2026 included an incorrect Stock Appreciation Right amount which has been corrected herein.
  • [F3]Each performance share represents a contingent right to receive one share of Stepan Company common stock.
  • [F4]The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
  • [F5]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
Signature
/s/ James A. Hart, Attorney-in-Fact for Sean T. Moriarty|2026-03-05

Documents

1 file
  • 4
    form4a.xml

    PRIMARY DOCUMENT